These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 30616104)

  • 21. Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemia working party of the European group for blood and marrow transplantation.
    Nagler A; Rocha V; Labopin M; Unal A; Ben Othman T; Campos A; Volin L; Poire X; Aljurf M; Masszi T; Socie G; Sengelov H; Michallet M; Passweg J; Veelken H; Yakoub-Agha I; Shimoni A; Mohty M
    J Clin Oncol; 2013 Oct; 31(28):3549-56. PubMed ID: 23980086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute myeloid leukemia of a primary hepatic carcinoma patient after liver transplantation: a case report and literature review.
    Wu WJ; Dong MM; Chen Y; He JS; Huang H; Cai Z
    Int J Clin Exp Pathol; 2015; 8(10):13655-60. PubMed ID: 26722593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inducible liver-specific overexpression of gankyrin in zebrafish results in spontaneous intrahepatic cholangiocarcinoma and hepatocellular carcinoma formation.
    Huang SJ; Cheng CL; Chen JR; Gong HY; Liu W; Wu JL
    Biochem Biophys Res Commun; 2017 Aug; 490(3):1052-1058. PubMed ID: 28668389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Outcomes for Pediatric Patients With Acute Myeloid Leukemia in Remission and Undergoing Allogeneic Hematopoietic Cell Transplantation With Myeloablative Conditioning Regimens Based on Either Intravenous Busulfan or Total Body Irradiation: A Report From the Japanese Society for Hematopoietic Cell Transplantation.
    Ishida H; Kato M; Kudo K; Taga T; Tomizawa D; Miyamura T; Goto H; Inagaki J; Koh K; Terui K; Ogawa A; Kawano Y; Inoue M; Sawada A; Kato K; Atsuta Y; Yamashita T; Adachi S
    Biol Blood Marrow Transplant; 2015 Dec; 21(12):2141-2147. PubMed ID: 26271192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a vestibular schwannoma xenograft zebrafish model for in vivo antitumor drug screening.
    Lee HJ; Yang YJ; Jeong S; Lee JD; Choi SY; Jung DW; Moon IS
    Laryngoscope; 2016 Dec; 126(12):E409-E415. PubMed ID: 27242319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous Busulfan Compared with Treosulfan-Based Conditioning for Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia: A Study on Behalf of the Acute Leukemia Working Party of European Society for Blood and Marrow Transplantation.
    Shimoni A; Labopin M; Savani B; Hamladji RM; Beelen D; Mufti G; Socié G; Delage J; Blaise D; Chevallier P; Forcade E; Deconinck E; Mohty M; Nagler A
    Biol Blood Marrow Transplant; 2018 Apr; 24(4):751-757. PubMed ID: 29247780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Busulfan, cyclophosphamide and total body irradiation as conditioning for allogeneic bone marrow transplantation for acute and chronic myeloid leukemia.
    Hirabayashi N; Goto S; Ishii M; Yuge M; Mitsuma A; Noda N
    Bone Marrow Transplant; 1998 Jun; 21(11):1079-83. PubMed ID: 9645568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In Vivo Targeting of Xenografted Human Cancer Cells with Functionalized Fluorescent Silica Nanoparticles in Zebrafish.
    Qin X; Laroche FFJ; Peerzade SAMA; Lam A; Sokolov I; Feng H
    J Vis Exp; 2020 May; (159):. PubMed ID: 32449736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Higher busulfan dose intensity appears to improve leukemia-free and overall survival in AML allografted in CR2: An analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Kharfan-Dabaja MA; Labopin M; Bazarbachi A; Socie G; Kroeger N; Blaise D; Veelken H; Bermudez A; Or R; Lioure B; Beelen D; Fegueux N; Hamladji RM; Nagler A; Mohty M
    Leuk Res; 2015 Sep; 39(9):933-7. PubMed ID: 26003666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II Trial of Reduced-Intensity Busulfan/Clofarabine Conditioning with Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Acute Myeloid Leukemia, Myelodysplastic Syndromes, and Acute Lymphoid Leukemia.
    El-Jawahri A; Li S; Ballen KK; Cutler C; Dey BR; Driscoll J; Hunnewell C; Ho VT; McAfee SL; Poliquin C; Saylor M; Soiffer RJ; Spitzer TR; Alyea E; Chen YB
    Biol Blood Marrow Transplant; 2016 Jan; 22(1):80-5. PubMed ID: 26260679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapy.
    Zhao Y; Shuen TWH; Toh TB; Chan XY; Liu M; Tan SY; Fan Y; Yang H; Lyer SG; Bonney GK; Loh E; Chang KTE; Tan TC; Zhai W; Chan JKY; Chow EK; Chee CE; Lee GH; Dan YY; Chow PK; Toh HC; Lim SG; Chen Q
    Gut; 2018 Oct; 67(10):1845-1854. PubMed ID: 29602780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel immunologic tolerance of human cancer cell xenotransplants in zebrafish.
    Zhang B; Shimada Y; Hirota T; Ariyoshi M; Kuroyanagi J; Nishimura Y; Tanaka T
    Transl Res; 2016 Apr; 170():89-98.e3. PubMed ID: 26746804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of Zebrafish Larval Xenografts and Tumor Behavior Analysis.
    Martinez-Lopez M; Póvoa V; Fior R
    J Vis Exp; 2021 Jun; (172):. PubMed ID: 34223839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetically engineered mesenchymal stromal cells produce IL-3 and TPO to further improve human scaffold-based xenograft models.
    Carretta M; de Boer B; Jaques J; Antonelli A; Horton SJ; Yuan H; de Bruijn JD; Groen RWJ; Vellenga E; Schuringa JJ
    Exp Hematol; 2017 Jul; 51():36-46. PubMed ID: 28456746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Xenograft Zebrafish Models for the Development of Novel Anti-Hepatocellular Carcinoma Molecules.
    Tonon F; Farra R; Zennaro C; Pozzato G; Truong N; Parisi S; Rizzolio F; Grassi M; Scaggiante B; Zanconati F; Bonazza D; Grassi G; Dapas B
    Pharmaceuticals (Basel); 2021 Aug; 14(8):. PubMed ID: 34451900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Innate immune evasion revealed in a colorectal zebrafish xenograft model.
    Póvoa V; Rebelo de Almeida C; Maia-Gil M; Sobral D; Domingues M; Martinez-Lopez M; de Almeida Fuzeta M; Silva C; Grosso AR; Fior R
    Nat Commun; 2021 Feb; 12(1):1156. PubMed ID: 33608544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of signaling between human CXCR4 and zebrafish ligands by the small molecule IT1t impairs the formation of triple-negative breast cancer early metastases in a zebrafish xenograft model.
    Tulotta C; Stefanescu C; Beletkaia E; Bussmann J; Tarbashevich K; Schmidt T; Snaar-Jagalska BE
    Dis Model Mech; 2016 Feb; 9(2):141-53. PubMed ID: 26744352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes after use of two standard ablative regimens in patients with refractory acute myeloid leukaemia: a retrospective, multicentre, registry analysis.
    Nagler A; Savani BN; Labopin M; Polge E; Passweg J; Finke J; Kyrcz-Krzemien S; Volin L; Anagnostopoulos A; Aljurf M; Beelen DW; Vigouroux S; Milpied N; Suarez F; Mohty M
    Lancet Haematol; 2015 Sep; 2(9):e384-92. PubMed ID: 26685771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of a fludarabine and melphalan combination-based reduced toxicity conditioning with myeloablative conditioning by radiation and/or busulfan in acute myeloid leukemia in Japanese children and adolescents.
    Ishida H; Adachi S; Hasegawa D; Okamoto Y; Goto H; Inagaki J; Inoue M; Koh K; Yabe H; Kawa K; Kato K; Atsuta Y; Kudo K
    Pediatr Blood Cancer; 2015 May; 62(5):883-9. PubMed ID: 25545836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. c-myb hyperactivity leads to myeloid and lymphoid malignancies in zebrafish.
    Liu W; Wu M; Huang Z; Lian J; Chen J; Wang T; Leung AY; Liao Y; Zhang Z; Liu Q; Yen K; Lin S; Zon LI; Wen Z; Zhang Y; Zhang W
    Leukemia; 2017 Jan; 31(1):222-233. PubMed ID: 27457538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.